gallium nitrate has been researched along with Lymphoma, Large B-Cell, Diffuse in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chitambar, CR; Kroft, SH; Yang, M | 1 |
| Bergeron, R; Honeysett, JM; Taetle, R | 1 |
2 other study(ies) available for gallium nitrate and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Gene expression analysis of gallium-resistant and gallium-sensitive lymphoma cells reveals a role for metal-responsive transcription factor-1, metallothionein-2A, and zinc transporter-1 in modulating the antineoplastic activity of gallium nitrate.
Topics: Antineoplastic Agents; Blotting, Northern; Cation Transport Proteins; Cell Proliferation; DNA-Binding Proteins; DNA, Complementary; Drug Resistance, Neoplasm; Electrophoretic Mobility Shift Assay; Gallium; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; Leukemia, Lymphoid; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Metallothionein; Oligonucleotide Array Sequence Analysis; Transcription Factor MTF-1; Transcription Factors; Transcription, Genetic | 2007 |
Combination iron depletion therapy.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Chelating Agents; Drug Screening Assays, Antitumor; Female; Gallium; Granulocytes; Hematopoietic Stem Cells; Humans; Immunoglobulin A; Iron Deficiencies; Leukemia, Myeloid; Lymphoma, Large B-Cell, Diffuse; Macrophages; Ovarian Neoplasms; Oxazoles; Receptors, Transferrin; Tumor Cells, Cultured | 1989 |